UFH-001 Human Breast Cancer Cell Line

Code: SCC210 D2-231

Application

This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement&r...


read more

Your Price
€1,315.40 EACH
€1,617.94 inc. VAT

Application

This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact [email protected].

The UFH-001 triple negative CAIX+ human breast cancer cell line is suitable as a model for studying the mechanisms of triple negative breast cancer progression, metastasis and migration.

Research CategoryCancer

Cell Line Description

Cancer Cells

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

The UFH-001 triple negative CAIX+ human breast cancer cell line constitutively expresses CAIX under both hypoxic and normoxic conditions, exhibits an aggressive TNBC phenotype in vivo, and supports tumor growth in a mouse xenograft model . The constitutive expression of CAIX in UFH-001 cells facilitates its evaluation as a potential therapeutic target both in vitro and in vivo. Source:UFH-001 cells are derived from MCF-10A cells, a spontaneously immortalized breast cancer epithelial cell line originating from breast tissue of a healthy female patient . UFH-001 cells were sorted for CAIX expression by flow cytometry .

Triple negative breast cancer (TNBC) accounts for 15-20% of breast cancer cases and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human EGF receptor 2 (HER2) . TNBC is typically more aggressive and difficult to treat than more common types of breast cancer and is more likely to recur after treatment. Carbonic anhydrase IX (CAIX) catalyzes the reversible hydration of carbon dioxide and is a marker for hypoxic regions of breast tumors. CAIX expression is associated with poor prognosis in TNBC and hormone-resistant breast tumors.

Quality

Each vial contains ≥ 1X106 viable cells.
Cells are tested negative for HPV-16, HPV-18, Hepatitis A, B, C, and HIV-1 & 2 viruses by PCR.
Cells are verified to be of human origin and negative for inter-species contamination from rat, mouse, chinese hamster, Golden Syrian hamster, and non-human primate (NHP) as assessed by a Contamination CLEAR panel by Charles River Animal Diagnostic Services.
Cells are negative for mycoplasma contamination.
Each lot of cells is genotyped by STR analysis to verify the unique identity of the cell line.

Storage and Stability

Store in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.

biological sourcehuman
technique(s)cell culture | mammalian: suitable
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.